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Problem Identification
• The seasonal flu vaccine, or “flu shot” has an overall efficacy of 60% in health adults,

according to a 2014 meta-analysis of inactivated flu vaccine studies1. It is associated with
significant reductions in laboratory-confirmed influenza illness, hospitalization for influenza
and pneumonia, and death due to influenza or its complications2.
• There are even greater reductions in morbidity and mortality in patients >65 years old and
those at risk, particularly pregnant women and immunocompromised patients3.
• In 2015-2016, flu vaccination rates in adults across the United States ranged from 33%
(Alaska) to 56% (Iowa), with 49% in Vermont4.
• In Vermont, vaccination rates increase with age (65% immunization rate in those >65),
higher levels of education (52% in college graduates), and socioeconomic status (50% in
households earning >$75,000/year) according to 2014 data5.

Public Health Cost
• The annual health cost of annual influenza epidemics averages $10.4 billion
in direct medical costs.

• This accounts for 3.1 million hospitalized days and 31.4 million outpatient
visits6.

• In Vermont, it is estimated that between 2008 and 2014, 4.8% of the
population received medical attention for influenza-related illness, accounting
for annual productivity costs of $8,938,0007.

Community Perspective
• Robert Luebbers, M.D., Physician at
South Burlington Family Medicine

• Jan Carney, M.D., Professor of Medicine at

UVM College of Medicine; Former Commissioner
of the Vermont Department of Health

• “I have noticed that there is a need

for more information I can give to
patients regarding concerns with the
flu shot. I hear the same sorts of
concerns ever year around this time
[November] as I recommend patients
getting vaccinated.”

• “I am interested in learning more

about why patients believe the flu
shot is any different from other
immunizations, such as the TDaP or
pneumonia vaccine.”

• “There is ample evidence supporting the flu shot
on the VT Department of Health and CDC
websites, but I recognize that patients may not
access these resources regularly.”

•

“Patients don’t spend most of their life in a
doctor’s office. We need to find ways to reach
patients outside of the office - putting up flu
shot posters in pharmacies and supermarkets, or
playing a video clip on flu shot safety in the
waiting room. Anything that will make them stop
and re-consider.”

Intervention Method: Pamphlet
• Content:
•

Ten of the most frequently-discussed questions and
concerns as taken from anecdotal experience with patients
during family medicine clerkship, as well as popular online
blogs and forums when inputting the keywords “safety of
flu shot” as an online search query.

•

Responses are paraphrased from online materials available
for health care professionals, such as UpToDate, as well as
publicly-available resources from the Centers for Disease
Control (CDC).

•

All material herein is intentionally written at the 8th grade
reading level.

•

As the VT Department of Health and most family
medicine practices already have pamphlets on the flu itself,
this material is specifically targeted to those who are
curious or skeptical about the safety of the flu vaccine.

Intervention Method: Pamphlet (cont…)
• Front Cover:
• Title: “Is the flu shot safe?”
• Back Cover:
• Contact information for 2-1-1 and
patient’s physician.

• Center page:
• Specific content detailing where the

content is sourced (physicians, CDC), as
well as links to reliable online resources
specifically for the inquisitive patient.

Response
• Providers were given copies of the pamphlet to review and it was positively received, with a

specific response that it fills an unmet need in the clinic, especially around October-January when
flu shots are administered.

• The pamphlet can be given either at the front desk upon check-in, or by the nurse rooming the

patient upon detecting no prior flu immunization that year. Providers themselves can briefly go
over the content with patients who remain skeptical during their visit or, at the very least, can give
patients a copy to bring home with them.

• Electronic copies of the handout were provided to healthcare providers and staff for future use
and distribution.

• The generic nature of the pamphlet – i.e. not specific to the South Burlington Family Practice –

allows for distribution to other family medicine clinics within the UVM network and possibly to
other outpatient clinics in Vermont.

Effectiveness and Limitations of Pamphlet
•

•

Evaluating effectiveness:

•

A 5- or 10-question survey can be given to every patient at the South Burlington Family Practice who is given a pamphlet to determine if it
appropriately addresses their specific concerns about the flu shot.

•

Further evaluation with a satisfaction rating would be helpful in analyzing if “they are more likely” or “less likely” to get a flu shot during that visit
or a future visit based on getting the pamphlet.

•

Will submit pamphlet to NCQA for formal medical verification of content, allowing further distribution and updated content on a semi-regular
basis.

Limitations:

•

This pamphlet was made under the assumption that other materials exist that adequately discuss the role of the influenza vaccine as part of a
patient’s comprehensive care, as well as a discussion regarding who is most likely to benefit (and for whom it is contraindicated) from getting the
shot.

•

Does not address the various sub-types of flu shots that exist – trivalent vs. quadrivalent and injection vs intranasal.

•

There was space enough for merely 10 questions. As such, there is a good chance that the patient has questions not explicitly discussed in the
pamphlet. There are website links that the patient can navigate for further investigation, however.

Recommendations for future projects
• Evaluating the effectiveness of the pamphlet in a random sampling of 50 patients, with specific questions
addressing patient satisfaction of the material, likeliness to vaccinate after reading, and

• A qualitative study characterizing the sources of health information that patients find online regarding the
“safety of flu vaccines”

• A qualitative survey given to a large sample of patients investigating in what ways they perceive the influenza
vaccine is different from other ‘required’ immunizations, such as Tdap and pneumococcal vaccines.

• Formal integration of pamphlet content into electronic health record to permit physicians to tack it on to
visit summary information that patients take home.

• Creation of a social media campaign and several print posters to place in local pharmacies, supermarkets, and
wholesale clubs. Each campaign or poster would include one “Did you know?” fact de-bunking a popular
misconception about the flu shot, as taken from the pamphlet content.
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